EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY

Laurent Peyrin-Biroulet  1     Edward V. Loftus Jr.  2     Silvio Danese  3     Severine Vermeire  4     William Sandborn  5     Ronald Fogel  6     Sandeep Nijhawan  7     Radoslaw Kempinski     Rafal Filip     Ihor Hospodarskyy     John McNally     Chohee Yun     Sally Zhao     Xiaopeng Liu     Chantal Tasset     Robin Besuyen     Mamoru Watanabe     Stefan Schreiber     Gerhard Rogler     Toshi    
1 Lorraine University,Vandoeuvre les Nancy,France
2 Mayo Clinic College of Medicine,Rochester,United States
3 Humanitas University,Milan,Italy
4 University Hospitals Leuven,Leuven,Belgium
5 University of California San Diego,La Jolla,United States
6 Clinical Research Institute of Michigan,Detroit,United States
7 SMS Medical College & Hos

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing